Aktienanalyse zu Aflac Incorporated (AFL)AFLAflac Incorporated

Aflac Incorporated provides financial protection to policyholders and customers through its subsidiaries in the United States and Japan. The Company's principal business is supplemental health and life insurance products. Its segments include Aflac Japan, which includes Aflac Life Insurance Japan Ltd. (ALIJ), and Aflac U.S., which includes American Family Life Assurance Company of Columbus (Aflac), American Family Life Assurance Company of New York (Aflac New York), Continental American Insurance Company (CAIC), Tier One Insurance Company (TOIC), and Aflac Benefits Solutions, Inc. (ABS). The Aflac Japan segment is the insurer in Japan in terms of cancer and medical (third sector insurance products) policies in force. The Company designs its United States insurance products to provide supplemental coverage for people who already have major medical or primary insurance coverage, as Aflac U.S. insurance policies pay benefits regardless of other insurance. It operates in the Financials sector (ACCIDENT & HEALTH INSURANCE industry).

Aflac Inc is currently a hold. The stock is priced at $114.54, with a forward P/E ratio of 15.20, indicating it is fairly valued compared to its earnings growth potential. However, the RSI is at 59.41, suggesting it is nearing overbought territory. The main risk is the downgrade from Mizuho, which lowered its price target to $107, indicating potential downside from current levels.

15 analysts cover AFL: 3 rate it Buy, 10 Hold and 2 Sell. The average price target is 110.90.